Industries Β· Biotechnology

Biotech quality systems thatkeep pace with innovation and control.

Cloudtheapp supports biotechnology companies that need structured quality, lab, supplier, documentation, and regulatory workflows while moving fast across R&D, scale-up, and commercial readiness.

21 CFR Part 11
GxP-aligned workflows
ICH quality principles
EU GMP / Annex 11
Two colleagues reviewing GxP document-control and lifecycle workflows on a glass display in a biotechnology lab, beside a benchtop bioreactor and sample vials
Scale-up ready

Processes can mature from early-stage control into broader operational governance.

Science to quality bridge

Lab and technical evidence can connect directly into quality action systems.

Configurable growth

The platform can expand as programs, sites, and regulatory pressure increase.

60+
Applications, one validated platform
21 CFR
Part 11 e-records and e-signatures
GxP
Aligned quality workflows across the lifecycle
1
Connected, inspection-ready system of record
Pressure points

What biotech organizations expect as they scale

The operational pressures are specific to fast-growing science. So are the responses Cloudtheapp is built to give.

Growth outpaces quality infrastructure

Rapid growth creates process complexity before the organization has a large quality infrastructure to absorb it.

Digitalize core quality, lab-adjacent, and regulatory workflows in a system that can evolve with maturity, not one you outgrow every funding stage.

R&D and quality need one source of truth

R&D, quality, and operations need better shared control of records, changes, and evidence than scattered tools provide.

Support deviations, investigations, CAPA, documents, training, and supplier oversight in one connected model, without tool sprawl.

Lab exceptions must reach quality fast

Lab and product-development exceptions must feed quality and risk decisions quickly, not sit in disconnected notebooks.

Provide a stronger validation and change-control foundation as the company grows into more regulated phases.

Partners expect visible operating discipline

Investors, partners, and regulators expect operating discipline that an early tool stack cannot demonstrate.

Give leadership visibility into execution, readiness, and repeat risk patterns across one operating model.
Applications map

Relevant Cloudtheapp applications for biotechnology

Each application ships with GxP-aligned workflows, records, and approvals, so your team starts with a regulated foundation, not a blank page.

Controlled Document Management

Documents

Learn More

Revision-controlled SOPs, forms, policies, and quality records with electronic workflows, read-and-understand, and 21 CFR Part 11 e-signature support.

Capabilities
  • Version history with periodic review and obsolescence
  • Read-and-understand assignments tied to training
  • Role-based review and approval routing
  • Immutable, inspection-ready audit trail
Compliance Coverage
21 CFR Part 11GxP document controlICH Q10
Why it matters

The controlled system of record partners, investors, and inspectors start from.

Explore all Applications

Explore the complete Applications Hub to discover 60+ prebuilt applications for Quality, Safety, Compliance, Manufacturing, Clinical, Laboratory, and Business Operations.

Core capabilities

How Cloudtheapp helps biotech teams scale responsibly

🧭

Digitalize quality as you mature

Core quality, lab-adjacent, and regulatory workflows in a system that can evolve from early-stage control into broader operational governance.
πŸ”—

One connected operating model

Deviations, investigations, CAPA, documents, training, and supplier oversight reinforce each other instead of living in silos.
πŸ§ͺ

Lab and quality, connected

Lab and technical evidence connect directly into quality action systems, so findings drive decisions quickly.
πŸ“Š

Leadership visibility

A stronger validation and change-control foundation, with clear visibility into execution, readiness, and repeat risk.
πŸ“Š

Advanced Analytics

Transform operational and quality data into meaningful insights with configurable dashboards, trend analysis, KPI tracking, and interactive reports that help teams identify risks, monitor performance, and support informed decision-making.
Workflow map

A common biotech quality loop

From signal to documented outcome, without losing traceability.

Capture event or finding
Assess scientific and quality impact
Drive correction and change
Retrain and document
Review scale-up risk

Each stage triggers approvals, linked actions, document updates, retraining, and management visibility inside one operating model, so every signal ends in a documented, traceable outcome.

Standards and regulations

Built for the obligations that define this buying decision

Mapped into workflows, approvals, and day-to-day evidence, not static policy text.

21 CFR Part 11

Electronic records and signatures with audit trail and controlled access.

GxP-aligned workflows

GLP, GCP, and GMP-adjacent controls mapped into everyday approvals and evidence.

ICH quality principles

ICH Q8 to Q10 quality-by-design and lifecycle thinking reflected in the operating model.

EU GMP / Annex 11

EU GMP and computerized-system expectations where operations enter regulated phases.

ICH Q10

Pharmaceutical Quality System model applied as programs and sites mature.

Inspection-ready document control

A controlled system of record built to survive partner, investor, and regulator scrutiny.

How we compare

Why this lands harder than a generic regulated-software page

Feature✦ CloudtheappTypical alternative
GxP workflows configured, not just claimedβœ“βœ—
Lab, deviations, CAPA, and change connectedβœ“βœ—
21 CFR Part 11 audit trail and e-signatures built inβœ“βœ—
Scales from R&D to commercial without a rebuildβœ“βœ—
Configurable without custom developmentβœ“βœ—
Inspection-ready evidence generated by daily workβœ“βœ—
One platform across quality, lab, and supplierβœ“βœ—
Customer stories

Trusted by quality teams that needed speed without losing control.

Frequently asked questions

Questions buyers are likely to ask

No. It is useful from early maturity onward, once controlled execution starts becoming essential.

Yes. Configurability and environment-based promotion are central strengths, so workflows change without starting over.

It gives smaller organizations a more structured operating model without requiring a large internal software group.

A focused first release can start with the highest-priority workflows, then expand into adjacent applications without rebuilding the operating model.

Ownership usually spans quality plus the teams closest to the work, with shared visibility across R&D, operations, regulatory, and leadership.

Yes. Everyday execution generates the same timestamps, approvals, linked records, and evidence that audits and reviews later rely on.

Book a demo

Turn biotech quality interest into a real buying conversation.

Book a walkthrough, explore the application set, or keep scanning adjacent industry pages in the same family.

πŸ”’ 21 CFR Part 11πŸ§ͺ GxP-readyπŸ”— Connected QMS☁️ AWS Hosted